INOZYME PHARMA, INC. Research and Development in Process
INOZYME PHARMA, INC. reported Research and Development in Process of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-03-15
- INOZYME PHARMA, INC. research and development in process for the quarter ending 2020-12-31 was $0.00.
- INOZYME PHARMA, INC. research and development in process for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- INOZYME PHARMA, INC. research and development in process for fiscal 2020 was $17.76M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-15 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $17.76M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $17.76M 10-Q · filed 2021-11-09 |